Emanuela Romano

Ipilimumab-dependent cell-mediated cytotoxicity of regulatory T cells ex vivo by nonclassical monocytes in melanoma patients

Emanuela Romano, Monika Kusio-Kobiałka, Periklis Foukas et al. · Proceedings of the National Academy of Sciences · 2015 · 585 citations · Full text

Life Sciences, Immunology, Oncology +17

Baseline Biomarkers for Outcome of Melanoma Patients Treated with Pembrolizumab

Benjamin Weide, Alexander Martens, Jessica C. Hassel et al. · Clinical Cancer Research · 2016 · 584 citations · Full text

Medicine, Clinical Sciences, Oncology +17

Frequencies of circulating MDSC correlate with clinical outcome of melanoma patients treated with ipilimumab

Christiane Meyer, Laurène Cagnon, Carla Costa-Nunes et al. · Cancer Immunology Immunotherapy · 2013 · 561 citations · Full text

Medicine, Immunology, Oncology +16

Baseline Peripheral Blood Biomarkers Associated with Clinical Outcome of Advanced Melanoma Patients Treated with Ipilimumab

Alexander Martens, Kilian Wistuba‐Hamprecht, Marnix Geukes Foppen et al. · Clinical Cancer Research · 2016 · 542 citations · Full text

Medicine, Immunology, Oncology +17

Anti–CTLA-4 therapy broadens the melanoma-reactive CD8 ⁺ T cell response

Pia Kvistborg, Daisy Philips, Sander Kelderman et al. · Science Translational Medicine · 2014 · 374 citations

Life Sciences, Immunology, Oncology +14